Skip to main content
. Author manuscript; available in PMC: 2018 Jul 2.
Published in final edited form as: Matern Child Health J. 2017 Dec;21(12):2178–2187. doi: 10.1007/s10995-017-2336-6

Table 3.

Population estimates of parents’ personal network characteristics by survey year and by non-influenza vaccination decision

Non-hesitant acceptor
Est (95% CI)
Hesitant acceptor
Est (95% CI)
Delayer
Est (95% CI)
Refuser
Est (95% CI)
Know someone whose child has experienced a severe reaction to a vaccine
 2012 8.4% (6.4–11.0%)* 14.4% (10.5–19.3%) 31.1% (22.4–41.4%)a 53.7% (40.4–66.4%)a,b
 2014 5.2% (4.1–6.5%)* 17.4% (13.0–23.0%) 35.1% (26.4–44.9%)a 46.0% (34.3–58.1%)a
Know someone who chose to delay their child’s vaccination(s)
 2012 32.1% (28.9–35.6%) 52.9% (45.5–60.1%) 80.6% (72.1–86.9%)a 90.0% (83.1–94.3%)a,c
 2014 33.1% (30.3–36.0%) 54.2% (47.9–60.4%) 87.4% (80.2–92.2%)a 85.5% (75.9–91.7%)a
Know someone who chose to refuse their child’s vaccination(s)
 2012 23.2% (20.4–26.2%) 38.6% (32.0–45.7%) 58.4% (48.4–67.8%)d,e 87.6% (77.3–93.6%)a,f
 2014 24.1% (21.7–26.7%) 44.1% (38.2–50.3%) 60.3% (49.7–70.0%)d,g 85.8% (76.5–91.8%)a,f

Est. weighted US population estimate, CI confidence interval

Severe reaction was defined as reactions that required medical attention and could not be treated at home

*

Rate is significantly different between survey years with p < 0.01

a

Estimates of this decision group differ significantly from “non-hesitant acceptors” and “hesitant acceptors” (p ≤ 0.001)

b

Estimates of this decision group differ significantly from “delayers” (p < 0.01)

c

Estimates of this decision group differs significantly from “delayers” (p < 0.05)

d

Estimates of this decision group differ significantly from “non-hesitant acceptors” (p ≤ 0.001)

e

Estimates of this decision group differ significantly from “hesitant acceptors” (p < 0.01)

f

Estimates of this decision group differ significantly from “delayers” (p < 0.001)

g

Estimates of this decision group differ significantly from “hesitant acceptors” (p < 0.05)